<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neurotropin, an inhibitor of the kallikrein-kinin system, has been used as an <z:chebi fb="29" ids="35480">analgesic</z:chebi> and <z:chebi fb="0" ids="50857">anti-allergic drug</z:chebi> in the clinic </plain></SENT>
<SENT sid="1" pm="."><plain>The aims of this study are to evaluate the effect of neurotropin on <z:hpo ids='HP_0002181'>brain edema</z:hpo> induced by permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats and collateral ventricular injection of <z:chebi fb="0" ids="3435">carrageenan</z:chebi> in mice and its mechanism </plain></SENT>
<SENT sid="2" pm="."><plain>Drugs were given i.v </plain></SENT>
<SENT sid="3" pm="."><plain>15 minutes after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in rats and immediately after <z:chebi fb="0" ids="3435">carrageenan</z:chebi> injection in mice </plain></SENT>
<SENT sid="4" pm="."><plain>Brain water content was determined by wet/dry weight ratio </plain></SENT>
<SENT sid="5" pm="."><plain>Results showed that neurotropin could reduce the <z:hpo ids='HP_0002181'>brain edema</z:hpo> induced by permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats and collateral ventricular injection of <z:chebi fb="0" ids="3435">carrageenan</z:chebi> in mice at doses of 3.0, 6.0, 30.0 and 30.0 NU.kg-1 body weight </plain></SENT>
<SENT sid="6" pm="."><plain>It also suggests that neurotropin reduced ischemic <z:hpo ids='HP_0002181'>brain edema</z:hpo> via inhibiting the kallikrein-kinin system </plain></SENT>
</text></document>